Flecainide therapy induced transient cardiomyopathy and left bundle branch block in a 67-year-old female, which improved upon cessation of the drug.
Case Report (n=1)
This case highlights that flecainide can rarely induce reversible left bundle branch block and transient cardiomyopathy.
Flecainide is an antiarrhythmic agent that has been reported to have numerous cardiotoxic effects, including the development of arrhythmias and the reduction of left ventricular ejection fraction (LVEF). However, it is not commonly reported as a cause for left bundle branch block and cardiomyopathy. In this case report, we present the case of a 67-year-old female patient who developed transient cardiomyopathy and left bundle branch block (LBBB) secondary to flecainide therapy. The patient's condition improved upon cessation of flecainide.
Chauhan et al. (Wed,) conducted a case report in Flecainide-induced left bundle branch block and transient cardiomyopathy (n=1). Flecainide was evaluated on Clinical improvement upon cessation of flecainide. Flecainide therapy induced transient cardiomyopathy and left bundle branch block in a 67-year-old female, which improved upon cessation of the drug.